MDXG 8-K 2026-10-28

MIMEDX GROUP, INC. (MDXG) 8-K dated 2026-10-28 — accession 0001376339-26-000094.

MIMEDX GROUP, INC. (MDXG) is a biotechnology company listed on US.

MIMEDX GROUP, INC. filed a 8-K on 2026-10-28. Accession 0001376339-26-000094.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MDXG revenue for 2025-12-31 was $418.6M. Net income was $48.6M. Revenue was up 20.0% from 2024-12-31 to 2025-12-31. MDXG currently screens at market cap $537.7M.

Not investment advice. The MDXG SEC hub lists recent forms. The stock page is the research view.